Fig. 2From: Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progressiona Selected variant frequency observed in tumour whole-genome sequencing (WGS) and circulating tumour DNA (ctDNA) at indicated timepoints in patient 3. b Summary of clinical history of patient 3 post-surgery with ctDNA sampling indicated by red arrowsBack to article page